Skip to main content

HBOT Evidence Digest · Pacific Hyperbarics

Carbon Monoxide Poisoning

FDA status

Recognized

Evidence

Grade A · Strong

Coverage

Medicare ✓

ICD-10

T58.11XA

Summary

HBOT rapidly clears carbon monoxide from the blood and reduces the risk of delayed neurological injury.

Typical protocol

2.8–3.0 ATA × 90–120 min, ASAP, up to 3 in 24h, 1–3 sessions · UHMS

The evidence (2)

  1. [1] Hyperbaric oxygen for carbon monoxide poisoning (Cochrane review)

    MIXED

    Buckley NA, Juurlink DN, Isbister G, et al. · Cochrane Database of Systematic Reviews · 2011 · PMID 21491385

    Reviewing seven trials with conflicting results, the authors concluded existing evidence neither firmly establishes nor excludes benefit, reflecting the ongoing clinical debate.

    Quality: Highlights heterogeneity across CO trials.

  2. [2] Hyperbaric oxygen for acute carbon monoxide poisoning

    POSITIVE

    Weaver LK, Hopkins RO, Chan KJ, et al. · New England Journal of Medicine · 2002 · n=152 · PMID 12362006

    Randomized trial in which three HBOT sessions reduced the rate of cognitive sequelae at 6 weeks after acute CO poisoning compared with normobaric oxygen.

    Quality: Landmark NEJM RCT; basis for HBOT in CO poisoning with neurological risk.

Prepared by Pacific Hyperbarics · pacifichyperbarics.com · (619) 423-8200. Evidence grade reflects our editorial reading of the cited literature, last reviewed July 2026. Educational summary for clinicians — not a treatment directive. Verify coverage criteria against current payer policy.